公司資料
Decipher Biosciences 股價、新聞與催化劑
- 股票代碼:
- DECI
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股價為何變動
目前無法取得 DECI 的收盤價變動背景。
公司概覽
業務概覽
Decipher Biosciences was a precision oncology diagnostics company focused on genomic tools for cancer risk and treatment selection before being acquired. Its story was rooted in molecular diagnostics and data-driven oncology decisions.
所在地與產業分類
Decipher was headquartered in the United States and listed on NASDAQ before the acquisition. It sat in oncology diagnostics rather than therapeutics.
商業模式特徵
The company depended on diagnostic adoption, reimbursement, and the ability to make genomic testing clinically indispensable. Investors historically watched test utilization and strategic interest.
生技產業定位
Decipher belongs to the historical precision-oncology diagnostics category. It is best thought of as a molecular-testing business that became valuable through strategic fit.
未來催化劑
- Decipher Biosciences is now a legacy / closeout story, so the catalysts are any remaining strategic or asset-resolution update. There is no active standalone growth story left.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。